3-Hydroxy medetomidine is a metabolite relevant to medetomidine exposure assessment in clinical and forensic toxicology. Its measurement supports investigations involving α2-adrenergic sedatives, including drug monitoring, impairment evaluation, and toxicology casework. As a CRM, it supports LC-MS/MS or GC-MS methods, helping address metabolite identification and matrix-related accuracy challenges.